ERYtech Pharma and Genzyme Corporation Sign Collaborative Research Agreement in Rare Diseases
18-Oct-2010
- France
Both companies will collaborate over the next 15 months to perform feasibility studies with encapsulating the enzyme and testing the new formulation in preclinical studies. Genzyme has an option to enter into a broader licensing agreement for development and commercialization of this product. Other terms of the deal were not disclosed.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.